The Effects of MediDrink Platinum+ and Fava Bean Protein Hydrolysate on Fitness in an Aged Population
NCT ID: NCT07322653
Last Updated: 2026-01-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
75 participants
INTERVENTIONAL
2025-09-10
2027-01-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of the Intervention Effectiveness of Branched-chain Amino Acids(BCAA) Combined With Medium-chain Fatty Acid(MCFA) Products in Sarcopenia Among Middle-aged and Elderly Individuals
NCT06376266
Impact of Plant Proteins and Exercise on Protein Metabolism in Older Adults
NCT07155824
Plant Protein Blend and Milk Protein Supplements in Older Individuals
NCT06403137
The Anabolic Properties of Fortified Plant-based Protein in Older People
NCT05711095
A Protein Supplementation and Exercise Strategy to Promote Muscle Protein Anabolism in Frail Elderly People
NCT01110369
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Other clinical endpoints measured as secondary endpoints will include hand grip strength, physical functioning via time up\&go test and changes in fat-free body mass.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MediDrink Platinum+
Base formula containing novel protein blend SPR-01 (Dosed appropriate to nutritional status with a minimum of 1200kcal/day as 600ml)
MediDrink Platinum+
MediDrink Platinum+ containing novel protein blend SPR-01
MediDrink Platinum+ and PeptiStrong
Base formula containing novel protein blend SPR-01 (Dosed appropriate to nutritional status with a minimum of 1200kcal/day as 600ml) and 2.4g/day PeptiStrong
MediDrink Platinum+ and PeptiStrong
MediDrink Platinum+ containing novel protein blend SPR-01 and PeptiStrong, fava bean protein hydrolysate
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MediDrink Platinum+
MediDrink Platinum+ containing novel protein blend SPR-01
MediDrink Platinum+ and PeptiStrong
MediDrink Platinum+ containing novel protein blend SPR-01 and PeptiStrong, fava bean protein hydrolysate
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI ≤ 25 kg/m²
* Malnourished (mini nutritional assessment MNA \<11
* Sarcopenic: SARC-F score ≥ 4
* Capable or oral feeding either alone or assisted
* Ambulatory (WHO PS/ECOG 0-3)
* Ability to complete questionnaires and self assess health status
* Ability to provide consent
Exclusion Criteria
* Acute Infection
* Proven Intestinal obstruction
* Co-morbidities requiring a special diet (diabetes, kidney disease etc.)
* Liver dysfunction
* Acute or chronic renal failure
* Uncontrollable nausea or vomiting
* Use of megestrol acetate or metabolic steroids
* Dietary supplement use in the last 3 months
* Known intolerance or allergy to the investigational products
* Participation in any clinical trial within the last 3 months
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medifood Hungary Innovation Kft
UNKNOWN
Nuritas Ltd
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Országos Korányi Pulmonológiai Intézet
Budapest, , Hungary
Sóstói Szivárvány Idősek Otthona
Nyíregyháza, , Hungary
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GINOP PLUSZ 2.1.1-21-102200048
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
SPR-K-2024-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.